Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP07778258.9Aexternal-prioritypatent/EP1984357B1/en
Application filed by Rigel Pharmaceuticals, Inc.filedCriticalRigel Pharmaceuticals, Inc.
Publication of CY1114807T1publicationCriticalpatent/CY1114807T1/en
Η παρούσα εφεύρεση αφορά σε ενώσεις 3-υδροξυφαινυλο-2,4-πυριμιδινοδιαμίνης του τύπου (Ι), καθώς και σε σχετικές συνθέσεις και μεθόδους για την θεραπευτική αντιμετώπιση διαφόρων αυτοάνοσων νόσων.The present invention relates to 3-hydroxyphenyl-2,4-pyrimidinediamine compounds of formula (I), as well as to related compositions and methods for the treatment of various autoimmune diseases.
CY20131101142T2006-02-172013-12-18
2,4-Pyrimidinodiamine Compounds for Therapeutic Treatment or Prevention of Autoimmune Diseases
CY1114807T1
(en)